pharma · EBV-induced Lymphomas · Coronary Artery Disease
Evidence Based Cataract
Evidence Based Cataract Study Group
News and analysis for Evidence Based Cataract on NovaPharmaNews — regulatory, clinical, and market coverage.
THOUSAND OAKS, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- THOUSAND OAKS, CA, CN
- Programs
- 10
- Drugs
- 8
- Patents
- 10
News & analysis
NovaPharmaNews articles mentioning Evidence Based Cataract — regulatory, clinical, and market coverage.
News and analysis for Evidence Based Cataract on NovaPharmaNews — regulatory, clinical, and market coverage.